Redx Pharma


Redx Pharma Plc is a drug discovery and development business creating high value cancer and fibrosis therapeutics. Redx Pharma uses its proven drug discovery expertise to generate development candidates that it will take into the clinic and then partner. 

Acceleris advised the founders of Redx from pre incorporation, introducing multiple levels of private and institutional funding to rapidly grow the organisation. Following five years of progress, Acceleris advised on the pre-IPO and IPO on to the AIM market of the London Stock Exchange. 

Patrick Molyneux